Therapeutic agent for inflammatory diseases, autoimmune diseases, fibrotic diseases, and cancer diseases
US12239643B2 · kind B2 · utility
0Cited by
7References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 27, 2019 |
| Grant date | Mar 4, 2025 |
| Priority date | — |
| Expiry date | Feb 14, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A therapeutic agent for treating at least one disease selected from the group consisting of inflammatory diseases, autoimmune diseases, fibrotic diseases, and cancer diseases, comprising: at least one selected from the group consisting of a compound represented by the following general formula (1) and pharmacologically acceptable salts thereof as an active ingredient.[In the formula (1),
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.